11-5857537-G-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001005168.3(OR52E8):āc.154C>Gā(p.Gln52Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000746 in 1,609,354 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001005168.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
OR52E8 | NM_001005168.3 | c.154C>G | p.Gln52Glu | missense_variant | 1/1 | ENST00000537935.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
OR52E8 | ENST00000537935.2 | c.154C>G | p.Gln52Glu | missense_variant | 1/1 | NM_001005168.3 | P1 | ||
TRIM5 | ENST00000412903.1 | c.-62+79864C>G | intron_variant | 1 | |||||
TRIM5 | ENST00000380027.5 | c.-543-1683C>G | intron_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000134 AC: 2AN: 149080Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000240 AC: 6AN: 250472Hom.: 0 AF XY: 0.0000369 AC XY: 5AN XY: 135462
GnomAD4 exome AF: 0.00000685 AC: 10AN: 1460274Hom.: 0 Cov.: 34 AF XY: 0.00000963 AC XY: 7AN XY: 726542
GnomAD4 genome AF: 0.0000134 AC: 2AN: 149080Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 72852
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 30, 2023 | The c.166C>G (p.Q56E) alteration is located in exon 1 (coding exon 1) of the OR52E8 gene. This alteration results from a C to G substitution at nucleotide position 166, causing the glutamine (Q) at amino acid position 56 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at